Global /South Korea /Healthcare /Drug Manufacturers - General /234690

GREEN CROSS WellBeing Corp.

234690

• KRX: 234690 • Delayed

13,470KRW -3%

8.87 USD

As of 14 June 2026, GREEN CROSS WellBeing Corp. has a market cap of $159.04M USD, ranking #22525 globally and #952 in South Korea. It ranks #2023 in the Healthcare sector, and #727 in the Drug Manufacturers - General industry.

Global Rank

22525

Country Rank

952

Sector Rank

2023

Industry Rank

727

Key Stats

Market Cap

$159.04MUSD

241.87B KRW

Enterprise Value

$206.46MUSD

313.45B KRW

Revenue (TTM)

$108.28MUSD

164.68B KRW

EBITDA (TTM)

$15.34MUSD

23.29B KRW

Net Income (TTM)

$6.58MUSD

10.01B KRW

EBITDA Margin

14%

Profit Margin

6.1%

PE Ratio

27.7

PS Ratio

1.5

PB Ratio

2.1

EV/EBITDA

14.9

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

309

Founded

2004

Website

greencrosswb.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3%	-8.1%	-8.2%	43%	45%	47%	75%	77%	6.1%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	234690 (주)녹십자웰빙 Ordinary Shares ISIN: KR7234690006 Shares Out.: Shares Outstanding: 17.956M¹ Shares Float: 8.413M² TV: TradingView: KRX: 234690 SA: Stock Analysis: KRX: 234690 YF: Yahoo Finance: 234690.KS GF: Google Finance: KRX: 234690 BA: Barron's: 234690 MS: Morningstar: XKRX: 234690	13,470 KRW	TV: TradingView: KRX: 234690 SA: Stock Analysis: KRX: 234690 YF: Yahoo Finance: 234690.KS GF: Google Finance: KRX: 234690 BA: Barron's: 234690 MS: Morningstar: XKRX: 234690

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About GREEN CROSS WellBeing Corp.

GREEN CROSS WellBeing Corporation provides personalized nutrition injections in South Korea. The company offers health supplements and food; prescription drugs; and aesthetics, as well as nutritional injections, including vitamins and antioxidants. GREEN CROSS WellBeing Corporation was founded in 2004 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 6K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 4K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 3K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 3K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 3K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 3K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 479K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 344K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 227K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 202K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 182K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 173K%	20.5	Switzerland

chevron_leftBack